Anonymous ID: 8cb5c6 March 11, 2021, 5:56 p.m. No.13188865   🗄️.is đź”—kun   >>8957 >>9051

>>13188841

here you go anon…

 

http://web.archive.org/web/20201201141647/https://www.cdc.gov/coronavirus/2019-ncov/vaccines/different-vaccines/mrna.html

 

There are currently no licensed mRNA vaccines in the United States. However, researchers have been studying and working with them for decades. Interest has grown in these vaccines because they can be developed in a laboratory using readily available materials. This means the process can be standardized and scaled up, making vaccine development faster than traditional methods of making vaccines.

 

mRNA vaccines have been studied before for flu, Zika, rabies, and cytomegalovirus (CMV). As soon as the necessary information about the virus that causes COVID-19 was available, scientists began designing the mRNA instructions for cells to build the unique spike protein into an mRNA vaccine.

 

Future mRNA vaccine technology may allow for one vaccine to provide protection for multiple diseases, thus decreasing the number of shots needed for protection against common vaccine-preventable diseases.

 

Beyond vaccines, cancer research has used mRNA to trigger the immune system to target specific cancer cells.

Anonymous ID: 8cb5c6 March 11, 2021, 6:34 p.m. No.13189074   🗄️.is đź”—kun   >>9123

>>13189051

So…

someone was already at the helm editing things to reflect a desired narrative. That one was from Dec. 01, 2020.

 

Earliest capture from Nov. 25, 2020

http://web.archive.org/web/20201125024733/https://www.cdc.gov/coronavirus/2019-ncov/vaccines/different-vaccines/mrna.html

 

There are currently no licensed mRNA vaccines in the United States. However, researchers have been studying and working with them for decades. Interest has grown in these vaccines because they can be developed in a laboratory using readily available materials. This means the process can be standardized and scaled up, making vaccine development faster than traditional methods of making vaccines.

 

mRNA vaccines have been studied before for flu, Zika, rabies, and cytomegalovirus (CMV). As soon as the necessary information about the virus that causes COVID-19 was available, scientists began designing the mRNA instructions for cells to build the unique spike protein into an mRNA vaccine.

 

Future mRNA vaccine technology may allow for one vaccine to provide protection for multiple diseases, thus decreasing the number of shots needed for protection against common vaccine-preventable diseases.

 

Beyond vaccines, cancer research has used mRNA to trigger the immune system to target specific cancer cells.